We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Creo Medical Group Plc | LSE:CREO | London | Ordinary Share | GB00BZ1BLL44 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.15 | 3.28% | 36.25 | 36.00 | 36.50 | 36.50 | 35.25 | 35.25 | 590,830 | 14:57:46 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 27.17M | -26.94M | -0.0746 | -4.86 | 130.95M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/4/2020 18:20 | Great to see CREO doing all they can to help with the fight against covid - tweet yesterday saying the team were working hard to "prepare & distribute CPAP ventilators & oxygen concentrators for local hospitals". Who cares if it's not revenue generating this is the sign of a good company to be invested in. | dplewis1 | |
23/3/2020 08:58 | Well done CREO. I no longer hold but always thought it was a good one. Good luck holders. | hazl | |
23/3/2020 07:10 | More nice news here - once this corona nightmare is under control this should do very well indeed. | dplewis1 | |
13/3/2020 14:16 | I picked up a few more of these today, seemed unfairly battered by the recent selloff although you could say that for a lot of shares I suppose | dplewis1 | |
13/2/2020 09:40 | Latest Job Vacancies... Production Supervisor Vacancy > 12/02/2020 As part of our ongoing expansion, we currently have an opportunity for a Production Supervisor to join our team. ALSO Stores Supervisor Vacancy > 12/02/2020 Over recent times, the team at Creo has expanded significantly to introduce additional experience into the design, manufacture, production and commercialisation of electrosurgical medical devices. As part of this expansion, we have an opportunity for a Stores Supervisor to join our team. | pecuniarum copia | |
12/2/2020 21:14 | I doubt it, there weren't last year. Interesting to see some Tweets from CREO regarding their hiring.. looks like they are gearing up for an increase in production: https://investors.cr | dplewis1 | |
12/2/2020 09:53 | Will there be videos posted from shares / cenkos of the presentations at Islington ? | haroldthegreat | |
11/2/2020 10:26 | They are the investor event in Islington today I believe. | dplewis1 | |
11/2/2020 09:35 | RNS: 11 February 2020 - Video abstracts featuring Speedboat procedures in India In this case, we used a new electrosurgical device to perform the entire procedure (Speedboat-RS2; Creo Medical Ltd, Chepstow, Wales, UK) and also We used a new multimodality knife for the entire procedure (Speedboat-RS2; Creo Medical Ltd., Chepstow, UK) | pecuniarum copia | |
30/1/2020 07:06 | Pretty solid TU. 2020 going to be a monster year for Creo by the sounds of it. | dplewis1 | |
07/1/2020 13:25 | Not a lot happening here of late so bought some more. Av now 185p | volsung | |
30/12/2019 16:12 | Good to see M&G taking 5% | dplewis1 | |
04/12/2019 07:58 | I'll be taking more shares here then! | dplewis1 | |
04/12/2019 07:51 | 'In addition to the Firm Placing and Placing, and as previously disclosed, the Company is also proposing to raise up to £6.6 million by way of an Open Offer which will be available to all Qualifying Shareholders on the Record Date. Further details of the Open Offer and the Open Offer timetable can be found in this announcement and the Circular.' | hazl | |
02/12/2019 07:05 | Hmm..more funds?! | dplewis1 | |
20/11/2019 07:32 | Exciting stuff and a beautiful chartA stock for 2020 to be sure | basem1 | |
20/11/2019 07:17 | 'The procedures were performed by Dr Amit Maydeo and Dr Gaurav Patil at the BIDS (Baldota Institute of Digestive Sciences) hospital in Mumbai. Dr Maydeo is currently the Chairman of the BIDS hospital and President of the Association of Interventional GI Endoscopy of India. Both cases were highly successful with Dr Maydeo citing "the microwave coagulation aspect of this device is excellent and not having to interchange devices mid-procedure makes this a great advancement in technology''. With further mentored clinical cases planned in the coming days in Delhi, Pune and Hyderabad, the expansion of Speedboat and the CROMA Advanced Energy Platform continues to gather pace.' | hazl | |
19/11/2019 14:08 | Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Ablation Equipment in these regions, from 2012 to 2023 (forecast), covering Asia-Pacific (China, Japan, Korea, India and Southeast Asia) North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) South America (Brazil, Argentina, Columbia) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Global Ablation Equipment market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Medtronic plc HistoSonics Inc Imricor Medical Systems Inc Mirabilis Medical Inc AngioDynamics Inc Creo Medical Ltd. Harmonic Medical Inc CPSI Biotech 16 mentioned CREO in the 6th position in their list above | hazl | |
19/11/2019 14:03 | Don't forget....in September... "''Furthermore, we added to our agreement with Hoya Group, Pentax Medical with a European framework distribution agreement covering France, Germany and Italy. In the period we had two successful FDA pre sub meetings and remain on track for a suite of cleared GI products during 2019. We continue to invest in our pipeline, positioning us well to become a leading advanced energy, minimally invasive, medical device company." " 'Creo Medical Group out of Chepstow in South Wales won clearance from the FDA for its Speedboat RS2 device and CROMA platform for endoscopic removal of cancerous and pre-cancerous lesions in the bowel.' 'This was one of the fastest FDA reviews of a 510(k) cleared medical device to date, with the company receiving the answer 49 days following submission of the request. The clearance was so unexpectedly expedient that Creo is now having to adjust its commercialization plans in the U.S. to bring the product to market earlier.' | hazl | |
18/11/2019 17:00 | Creo Medical is delighted to have won two categories at the South Wales Argus Business Awards, held on 14 November 2019 in Newport. Creo have been awarded both the Innovative Business of the Year and Business of the Year awards. Now in their second year, the awards recognise and showcase businesses across the South Wales region and are held by the South Wales Argus newspaper in partnership with Newport Now Business Improvement District, alongside other sponsors. Creo CEO Craig Gulliford said “Wow, a fantastic surprise to win both these awards which recognise and reward the truly hard work, determination and imaginative approach of the team here at CREO. Great news for everyone as we head into Christmas!” | hazl |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions